dr. hutson on lenvatinib/everolimus combo in rcc
Published 7 years ago • 542 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
0:58
dr. funahashi on enhanced activity with lenvatinib/everolimus combo in rcc
-
2:51
practical experience with lenvatinib/everolimus in rcc
-
6:42
the role of lenvatinib in advanced rcc
-
3:39
managing patients on lenvatinib/everolimus in mrcc
-
6:22
mtor/tki combination therapy in kidney cancer
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
5:32
lenvatinib and everolimus for advanced rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
1:14
dr. larkin on lenvatinib plus everolimus in patients with rcc
-
3:42
lenvatinib and everolimus in relapsed/refractory mrcc
-
1:36
dr. thomas hutson on drug sequencing in renal cell carcinoma
-
4:27
lenvatinib in renal cell carcinoma
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
2:37
lenvatinib/everolimus in refractory mrcc
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
11:30
immune checkpoint inhibitors in combination therapy for rcc
-
8:34
promising treatments in advanced rcc
-
4:28
metastatic renal cell carcinoma: lenvatinib phase ii data